{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33112023",
  "DateCompleted": {
    "Year": "2021",
    "Month": "01",
    "Day": "13"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "11",
        "Day": "09"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1111/dth.14468"
    ],
    "Journal": {
      "ISSN": "1529-8019",
      "JournalIssue": {
        "Volume": "33",
        "Issue": "6",
        "PubDate": {
          "Year": "2020",
          "Month": "Nov"
        }
      },
      "Title": "Dermatologic therapy",
      "ISOAbbreviation": "Dermatol Ther"
    },
    "ArticleTitle": "Isolated maculopapular eruption localized to head and neck: A cutaneous sign of COVID-19 infection.",
    "Pagination": {
      "StartPage": "e14468",
      "MedlinePgn": "e14468"
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-4748-1556"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dermatology Department, Ankara University, Ankara, Turkey."
          }
        ],
        "LastName": "Farabi",
        "ForeName": "Banu",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Dermatology Department, Tokat State Hospital, Tokat, Turkey."
          }
        ],
        "LastName": "Atak",
        "ForeName": "Mehmet F",
        "Initials": "MF"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Letter"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Dermatol Ther",
    "NlmUniqueID": "9700070",
    "ISSNLinking": "1396-0296"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Glucocorticoids"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Glucocorticoids"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "drug effects",
        "pathology",
        "virology"
      ],
      "DescriptorName": "Skin"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy",
        "virology"
      ],
      "DescriptorName": "Skin Diseases, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Treatment Outcome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ]
}